Due to changes in hazardous drug handling throughout British Columbia, Northern Health is transitioning to a methotrexate pre-filled syringe (PFS) format at select sites.
Newsroom
The Issue: Sanofi has been unable to provide adequate order volumes of some formats of enoxaparin (Lovenox®) to meet usage requirements across NH. However, three biosimilar enoxaparin products are now available in Canada and on formulary (Noromby™, Redesca®, and Inclunox®).
The Issue: Moxifloxacin 400 mg ready-to-use (RTU) injectable bags are on full backorder from the sole source vendor and all NH supply will expire on October 31, 2021.
NH October Formulary Update - Effective October 5, 2021
For more information, please contact:
On September 13, 2021, the Provincial Health Officer (PHO) announced that all employees, medical staff and other service providers who work in identified care locations in the health sector will be required to be fully (two doses) vaccinated against COVID-19 by October 26, 2021.
The Issue: Sandoz recently recalled several lots of losartan oral tablets (25 mg, 50 mg, and 100 mg) due to the presence of an azido impurity above acceptable levels for long term use. The majority of NH supply has been affected and several sites now have no stock.